Figure 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer

<p>Flow chart of study population. Note: Extending adjuvant hormone therapy was defined as continuing the therapy for ≥6 months and filling ≥2 prescriptions of tamoxifen or aromatase inhibitors beyond the 5-year adjuvant hormone therapy.</p>

Salvato in:
Dettagli Bibliografici
Autore principale: Erwei Zeng (14958443) (author)
Altri autori: Wei He (14958446) (author), Arvid Sjölander (14958449) (author), Jenny Bergqvist (14958452) (author), Kamila Czene (14958455) (author)
Pubblicazione: 2025
Soggetti:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
Descrizione
Riassunto:<p>Flow chart of study population. Note: Extending adjuvant hormone therapy was defined as continuing the therapy for ≥6 months and filling ≥2 prescriptions of tamoxifen or aromatase inhibitors beyond the 5-year adjuvant hormone therapy.</p>